DJ Eli Lilly & Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ slid 1.06% to $929.55 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.02% to 6,886.24 and the Dow Jones Industrial Average rising 0.63% to 48,218.25.
This was the stock's second consecutive day of losses.
Eli Lilly & Co. closed 18.03% short of its 52-week high of $1,133.95, which the company reached on January 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.21% to $237.96, Pfizer Inc. $(PFE)$ rose 1.56% to $27.34, and AbbVie Inc. $(ABBV)$ fell 0.71% to $206.47.
Trading volume (2.1 M) remained 1.1 million below its 50-day average volume of 3.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 13, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
